MBX Biosciences Inc (MBX) PT Raised to $50 at Stifel on PEP Platform Validation
Tweet Send to a Friend
Stifel analyst Annabel Samimy raised the price target on MBX Biosciences Inc (NASDAQ: MBX) to $50.00 (from $45.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
